IPO Detail
Speciality Medicines Limited
SMENot investment advice. Read RHP before applying.
Overview
About the Company
Speciality Medicines Limited is an IPO issuer in India, operating in the Pharmaceutical sector, with proposed/listed trading on BSE SME. The issue size referenced by the source is approximately ₹29.14 crore.
New to IPO analysis? You may review our structured guides on how IPO allotment works and IPO subscription meaning to better understand demand and allocation mechanics.
Issue
IPO Issue Details
Issue Price
₹124 – ₹124
Face Value
₹10
Issue Size
29.14
Fresh Issue
29.14
Listing At
BSE SME
Lead Manager
Unistone Capital Private Limited
Registrar
Skyline Financial Services Private Limited
Lot Size
1000
For category-wise quota breakdown such as QIB, HNI, and Retail allocation, refer to our IPO quota structure explanation.
Milestones
Timeline
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Subscription
Live Subscription Details
Subscription Progress
Subscription data sourced from exchange updates. Values represent times subscribed (x).
Learn how subscription categories are allocated by reading our guide on QIB, HNI and Retail IPO quota structure.
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Allotment Probability Calculator
SEBI-compliant allotment prediction based on live subscription data.
Chance of Allotment
—
Subscription data is currently unavailable.
GMP (Grey Market Premium)
GMP Overview
—
Updated —
Issue price comparison unavailable
GMP is unofficial and indicative only. It does not guarantee listing price or returns.
GMP is unofficial and indicative. To understand interpretation logic and limitations, read our IPO Grey Market Guide or begin with what IPO GMP means.
Trend
GMP Trend
No GMP data yet. Updates will appear once available.
Investment
Market Lot Details
Investors can bid in multiples of the lot size. Final investment depends on the cutoff price.
Allocation
Reservation Details
QIB
50%
NII
15%
RII
35%
Employee
—
Issue Summary
Objectives of Issue
The IPO proceeds are proposed to be used to fund working-capital requirements, repay or reduce borrowings, meet general corporate purposes.
Financials
Key Financial Metrics
EPS Pre IPO
—
EPS Post IPO
—
P/E Pre
9.27
P/E Post
—
ROCE
—
Debt / Equity
—
PAT Margin
—
Market Cap
108.94
Financial figures sourced from official offer documents. Always verify with the RHP.
Ownership
Promoter Holdings
Pre Issue
60.14%
Post Issue
0%
Contacts
Company & Registrar Details
Company Address: —
Phone: —
Email: —
Website: —
Registrar: Skyline Financial Services Private Limited
Registrar Phone: —
Registrar Email: —
Registrar Website: —
SME Specific
Market Maker Details
Market Maker Shares Offered
—
Market Maker Reservation (%)
—
Applicable only for SME IPOs where a market maker is appointed to provide liquidity post listing.
Documents
Important Links
Performance
Listing Performance
Listing Exchange
BSE SME
Listing Price
₹124
Listing Gain
0%
Application
How to Apply
UPI Method (ASBA)
Log in to your broker's app or net banking, navigate to the IPO section, select this IPO, enter lot quantity, and authorise via UPI mandate. Funds are blocked, not debited, until allotment.
ASBA via Net Banking
Log in to your bank's net banking portal, go to the IPO / ASBA section, fill in the bid details, and submit. Your bank will block the required amount automatically.
Allotment & Refund
Allotment status is typically available within 6 days of the IPO close date. Refunds for unallotted bids are credited within 2 working days post allotment.
You may also review the complete IPO allotment process explanation to understand lottery mechanics and refund timelines.
Qualitative Factors
Strengths & Risks
Company Strengths
Source material identifies the issuer with the Pharmaceutical sector; detailed strengths should be confirmed from the DRHP/RHP before publishing investment-facing claims.
Company Risks
IPO investors should review the DRHP/RHP risk factors, issue structure, valuation, subscription data, and market conditions before applying.
Legal Disclaimer
Information is sourced from publicly available exchange filings and company offer documents. GMP is unofficial and indicative. IPOCraft does not provide investment advice.
Research Before You Apply